Bon Natural Life Ltd

Bon Natural Life Ltd(BON)股票分析

$1.145

+0.005 (+0.43%)收盤時

Loading chart…
High
1.150
Open
1.130
VWAP
1.14
Vol
3.72K
Mkt Cap
9.09M
Low
1.130
Amount
4.24K
EV/EBITDA, TTM
0.00

Bon Natural Life Ltd is a company principally engaged in the manufacturing and sales of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements, such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The Company's product categories include fragrance compounds, health supplements (natural, functional active ingredients for powder drinks) and bioactive food ingredients. Fragrance compounds product category includes clary sage extract products and lavender essential oil. Bioactive food ingredients include stachyose, milk thistle extracts, apple extracts, phloretin and pomegranate extract products. The Company’s products are applied in the functional food, personal care, cosmetic and pharmaceutical industries.

www.bnlus.com

AI analysis of Bon Natural Life Ltd (BON)

buy

Bon Natural Life Ltd appears to be a good buy right now, primarily due to its low forward P/E ratio of 2.35, which suggests that the stock is undervalued compared to its earnings potential. Additionally, the recent announcement of a $1 million share buyback program has positively impacted investor sentiment, leading to a 10% increase in share price shortly after the announcement. However, the main risk is the negative P/E ratio of -7.35, indicating potential financial instability.

估值指標

The current forward P/E ratio for Bon Natural Life Ltd (BON) is 2.35, compared to its 5-year average forward P/E of 4.79.

Forward P/E

Fair
5Y Average P/E
4.79
Current P/E
2.35
高估
18.11
低估
-8.54

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
1.72
Current EV/EBITDA
0.00
高估
4.13
低估
-0.69

Forward P/S

Fair
5Y Average P/S
0.35
Current P/S
0.00
高估
0.75
低估
-0.06

Alphio AI Price Scenarios for BON

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%BON

$1.68

情境價格

B

Base

Base · 50%BON

$1.48

情境價格

B

Bear

Bear · 25%BON

$1.41

情境價格

事件時間軸

2026-03-31 (ET)

09:10:00

Bon Natural Life Enters Cooperation Agreement with Tigerbone Group

2026-02-19 (ET)

09:10:00

Bon Natural Life Develops Apple Polyphenol Anti-Aging Mask

2025-12-10 (ET)

05:10:00

Bon Natural Life Launches New Product and Signs $12M Collaboration Agreement

2025-11-25 (ET)

09:44:21

Bon Natural Life reveals $26M partnership deal with Beijing Huahai Keyuan

2025-09-09 (ET)

08:33:15

Bon Natural Life Signs $18M Partnership Agreement in China

資訊

BON FAQ — answered by Alphio AI

Bon Natural Life Ltd is a company principally engaged in the manufacturing and sales of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements, such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The Company's product categories include fragrance compounds, health supplements (natural, functional active ingredients for powder drinks) and bioactive food ingredients. Fragrance compounds product category includes clary sage extract products and lavender essential oil. Bioactive food ingredients include stachyose, milk thistle extracts, apple extracts, phloretin and pomegranate extract products. The Company’s products are applied in the functional food, personal care, cosmetic and pharmaceutical industries. It operates in the Healthcare sector (MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS industry).

Bon Natural Life Ltd appears to be a good buy right now, primarily due to its low forward P/E ratio of 2.35, which suggests that the stock is undervalued compared to its earnings potential. Additionally, the recent announcement of a $1 million share buyback program has positively impacted investor sentiment, leading to a 10% increase in share price shortly after the announcement. However, the main risk is the negative P/E ratio of -7.35, indicating potential financial instability.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始